Addressing the financial burden of cancer treatment: From copay to can’t pay
Cette étude américaine analyse les coûts des traitements restant à charge du patient et évalue l'impact de ces difficultés financières sur leur adhésion aux traitements et sur leur qualité de vie
Patients with cancer spend a substantial amount of money on health care services and are at higher risk for financial hardship, including personal bankruptcy, than the general population.1 Evidence that this so-called financial toxicity has a negative impact on clinical outcomes is emerging. High out-of-pocket spending on cancer treatment has been shown in recent studies to be associated with decreased treatment adherence and poorer quality of life.2- 4 The growing intersection between the financial and clinical aspects of cancer care represents an emerging challenge to the oncology community. In this article, we present 5 strategies to address the financial burden of cancer treatment.